Revolutionary Blood Screening Shows Promise for Early Cancer Detection in Major Trial
A groundbreaking blood test has shown remarkable results in detecting over 50 cancer types at early stages. The Galleri test reportedly increased cancer detection rates more than seven-fold when combined with standard screening methods, according to trial data presented at a major medical conference.
Major Cancer Screening Breakthrough Emerges From Large-Scale Trial
A revolutionary blood test capable of detecting more than 50 types of cancer has demonstrated highly promising results in one of the largest interventional screening trials conducted to date, according to reports from the European Society for Medical Oncology Congress 2025. The PATHFINDER 2 study of the Galleri multi-cancer early detection test reportedly showed a more than seven-fold increase in cancer detection rates when used alongside standard recommended cancer screenings.